Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole

被引:345
|
作者
Banasr, M. [2 ]
Chowdhury, G. M. I. [3 ,4 ]
Terwilliger, R. [2 ]
Newton, S. S. [2 ]
Duman, R. S. [2 ]
Behar, K. L. [3 ]
Sanacora, G. [1 ,2 ]
机构
[1] Yale Univ, Sch Med, Dept Psychiat, CNRU CMHC, New Haven, CT 06437 USA
[2] Yale Univ, Sch Med, Ribicoff Res Facil, New Haven, CT 06437 USA
[3] Yale Univ, Sch Med, Magnet Resonance Res Ctr, New Haven, CT 06437 USA
[4] Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06510 USA
关键词
antidepressant; stress; glia; glutamate; glutamate transporter; metabolism; FIBRILLARY ACIDIC PROTEIN; MEDIAL PREFRONTAL CORTEX; MAJOR DEPRESSION; MOOD DISORDERS; FLUOXETINE TREATMENT; ENERGY-METABOLISM; CEREBRAL-CORTEX; NMDA RECEPTOR; NEURONAL SIZE; RAT;
D O I
10.1038/mp.2008.106
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Growing evidence indicates that glia pathology and amino-acid neurotransmitter system abnormalities contribute to the pathophysiology and possibly the pathogenesis of major depressive disorder. This study investigates changes in glial function occurring in the rat prefrontal cortex (PFC) after chronic unpredictable stress (CUS), a rodent model of depression. Furthermore, we analyzed the effects of riluzole, a Food and Drug Administration-approved drug for the treatment of amyotrophic laterosclerosis, known to modulate glutamate release and facilate glutamate uptake, on CUS-induced glial dysfunction and depressive-like behaviors. We provide the first experimental evidence that chronic stress impairs cortical glial function. Animals exposed to CUS and showing behavioral deficits in sucrose preference and active avoidance exhibited significant decreases in C-13-acetate metabolism reflecting glial cell metabolism, and glial fibrillary associated protein (GFAP) mRNA expression in the PFC. The cellular, metabolic and behavioral alterations induced by CUS were reversed and/or blocked by chronic treatment with the glutamate-modulating drug riluzole. The beneficial effects of riluzole on CUS-induced anhedonia and helplessness demonstrate the antidepressant action of riluzole in rodents. Riluzole treatment also reversed CUS-induced reductions in glial metabolism and GFAP mRNA expression. Our results are consistent with recent open-label clinical trials showing the drug's effect in mood and anxiety disorders. This study provides further validation of hypothesis that glial dysfunction and disrupted amino-acid neurotransmission contribute to the pathophysiology of depression and that modulation of glutamate metabolism, uptake and/or release represent viable targets for antidepressant drug development. Molecular Psychiatry (2010) 15, 501-511; doi:10.1038/mp.2008.106; published online 30 September 2008
引用
收藏
页码:501 / 511
页数:11
相关论文
共 7 条
  • [1] Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole
    M Banasr
    G M I Chowdhury
    R Terwilliger
    S S Newton
    R S Duman
    K L Behar
    G Sanacora
    Molecular Psychiatry, 2010, 15 : 501 - 511
  • [2] Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioural deficits by the glutamate-modulating drug riluzole
    Sanacora, G.
    Banasr, M.
    Chowdhury, G.
    Lepak, A.
    Behar, K.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S208 - S208
  • [3] Glial Pathology in an Animal Model of Depression:Stress-Induced Cellular, Metabolic and Behavioural Deficits
    Sanacora, Gerard
    BIOLOGICAL PSYCHIATRY, 2011, 69 (09) : 28S - 28S
  • [4] A glutamate-modulating drug riluzole reduces anxiety-like behaviors in olfactory bulbectomized rats, an animal model of depression
    Saitoh, Akiyoshi
    Yamada, Misa
    Takahashi, Kou
    Iwai, Takashi
    Inagaki, Masatoshi
    Yamada, Mitsuhiko
    NEUROSCIENCE RESEARCH, 2011, 71 : E396 - E396
  • [5] Clomipramine treatment reversed the glial pathology in a chronic unpredictable stress-induced rat model of depression
    Liu, Qiong
    Li, Bing
    Zhu, Hai-Yan
    Wang, Yan-Qing
    Yu, Jin
    Wu, Gen-Cheng
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 (11) : 796 - 805
  • [6] Magnolol treatment reversed the glial pathology in an unpredictable chronic mild stress-induced rat model depression
    Li, Lu-Fan
    Yang, Jie
    Ma, Shi-Ping
    Qu, Rong
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2013, 711 (1-3) : 42 - 49
  • [7] Tinospora cordifolia Ameliorates Behavioral Deficits in Conditioned Fear and Single Prolonged Stress-Induced Preclinical PTSD Model in Mice by Modulating Translocator Protein (18kDa, TSPO)
    Ranjan, Gaurav
    Sunita, Priyashree
    Bose, Pritha
    Banerjee, Sugato
    Pattanayak, Shakti
    PHARMACOGNOSY MAGAZINE, 2022, 18 (78) : 247 - 255